Asbestos And Related Diseases In Western Australia
Funder
National Health and Medical Research Council
Funding Amount
$404,727.00
Summary
This project will extend the follow-up of large, well established groups of people who have experienced significant exposure to blue asbestos, either through their jobs or environmentally. Mesothelioma, lung cancer and asbestosis are common among these groups. This study will provide information on the effects of different levels of exposure to blue asbestos. Ways in which these diseases may be prevented through the diet and other lifestyle habits will be closely examined. This project provides ....This project will extend the follow-up of large, well established groups of people who have experienced significant exposure to blue asbestos, either through their jobs or environmentally. Mesothelioma, lung cancer and asbestosis are common among these groups. This study will provide information on the effects of different levels of exposure to blue asbestos. Ways in which these diseases may be prevented through the diet and other lifestyle habits will be closely examined. This project provides important data on the dose-response effects of a known carcinogen. Due to the integrated nature of our already established follow up systems we are in a unique position worldwide to achieve these aims. The dose response relationships between exposure and disease identified by this study will contribute to occupational health and safety exposure standards and compensation policy in Australia. The information on lifestyle factors is appropriate for use in many different health promotion interventions. Ongoing contact with the cohorts is critical to our involvement in collaborative preventative and biological studies.Read moreRead less
This project will update the Wittenoom cohorts by tracing cancers and deaths in Australia and Italy. This will improve risk estimates of lung cancer and mesothelioma. In particular we will see if that risk declines with more than 40 years since exposure, in collaboration with Italian colleagues. We will continue developing an interactive community website to act as a support platform, a layman's bridge to medical research knowledge, public health information and an archive of personal stories.